BREZTRI

Description

BREZTRI 160/7.2/5MCG is a prescription inhalation aerosol used for maintenance treatment in patients with COPD. It combines three active ingredients in one inhaler and gives patients a practical daily option for long-term respiratory support.

This product comes in 1 inhaler (120 puffs), which makes it a convenient choice for ongoing treatment plans. In addition, BREZTRI 160/7.2/5MCG is designed for regular maintenance use, not for sudden breathing attacks. As a result, it fits well into structured daily care under medical supervision.

Why Choose BREZTRI?

• Triple-Combination Formula: It combines budesonide, glycopyrrolate, and formoterol in one inhaler.
• 120 Puffs Per Inhaler: The inhaler is supplied in a practical 120-puff format.
• Daily Maintenance Support: It is indicated for maintenance treatment of COPD.
• Convenient Inhalation Format: It offers an easy and professional inhaler option for regular use.

Common Usage & Available Strengths

BREZTRI 160/7.2/5MCG is supplied as an inhalation aerosol in 1 inhaler (120 puffs). The FDA prescribing information states that the recommended dose is 2 inhalations twice daily, and each actuation delivers the labeled strength per inhalation. Therefore, patients should use it exactly as directed by a licensed healthcare provider.